PCN48 Costs Associated to Treatment of Metastatic HER2 Positive Breast Cancer After Progression to Trastuzumab Under the Perspective of the Brazilian Private Health Care System

Autor:	O.A.C. Clark, V. Teich
Rok vydání:	2012
Předmět:	Oncology medicine.medical_specialty business.industry Health Policy Perspective (graphical) Public Health Environmental and Occupational Health Trastuzumab Internal medicine HER2 Positive Breast Cancer Health care medicine skin and connective tissue diseases business medicine.drug
Zdroj:	Value in Health. 15(4)
ISSN:	1098-3015
DOI:	10.1016/j.jval.2012.03.1165
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4cda791ce6c261c86c2be1986df58043 Zobrazit plný text záznamu Full Text from ScienceDirect